![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/113 | |
A61K 31/713 | |||
A61K 31/711 | |||
A61P 11/00 | |||
A61P 43/00 | |||
A61K 45/06 | |||
A61K 31/404 | |||
A61K 31/47 | |||
A61K 31/7105 | |||
A61K 31/443 |
(11) | Number of the document | 3044316 |
(13) | Kind of document | T |
(96) | European patent application number | 14766458.5 |
Date of filing the European patent application | 2014-09-12 | |
(97) | Date of publication of the European application | 2016-07-20 |
(45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2014/069522 |
Date | 2014-09-12 |
(87) | Number | WO 2015/036552 |
Date | 2015-03-19 |
(30) | Number | Date | Country code |
13306250 | 2013-09-12 | EP |
(72) |
TAULAN-CADARS, Magali, FR
|
(73) |
INSERM - Institut National de la Santé et de la Recherche Médicale,
101, rue de Tolbiac, 75013 Paris,
FR
Université de Montpellier, 163 Rue Auguste Broussonnet, 34090 Montpellier, FR |
(54) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS |